The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 2 trial of minocycline versus placebo to prevent neuropathy in patients (pts) with multiple myeloma (MM).
Sheeba K. Thomas
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Patrick M. Dougherty
No relevant relationships to disclose
Loretta A. Williams
No relevant relationships to disclose
Xin Shelley Wang
No relevant relationships to disclose
Seema Prasad
No relevant relationships to disclose
Nina Shah
No relevant relationships to disclose
Jatin J. Shah
No relevant relationships to disclose
Michael Wang
No relevant relationships to disclose
Donna M. Weber
No relevant relationships to disclose
Robert Z. Orlowski
No relevant relationships to disclose
Sergio Giralt
No relevant relationships to disclose
Charles S. Cleeland
No relevant relationships to disclose